NLRC4 and hepatocellular adenoma: As shown in Fig 4B and 4C, the NLRC4 level in both serum (460.2±62.3 versus 289±55.1 [control], P<0.05) and fetal membranes (1.50±0.16 versus 0.99±0.08 [control], P<0.01) of patients with TPROM combined with HCA was slightly higher than that of patients with TPROM with non-HCA.